Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters
Authors
Keywords
Nonalcoholic steatohepatitis, Fibrosis, Heart failure, Diastolic dysfunction, Hamster
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 117, Issue -, Pages 154707
Publisher
Elsevier BV
Online
2021-01-13
DOI
10.1016/j.metabol.2021.154707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship between Heart Disease and Liver Disease: A Two-Way Street
- (2020) Hamza El Hadi et al. Cells
- Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model
- (2020) François Briand et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift
- (2019) Christopher J Nolan et al. Diabetes & Vascular Disease Research
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
- (2019) Jonathan D. Roth et al. Scientific Reports
- Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice
- (2019) Hung-Cheng Tsai et al. Biomed Research International
- Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
- (2019) Menso J. Westerouen Van Meeteren et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review
- (2019) Ieva Stundiene et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
- (2019) Claudio Tana et al. International Journal of Environmental Research and Public Health
- Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Milton Packer AMERICAN JOURNAL OF MEDICINE
- The Evolution from Hypertension to Heart Failure
- (2019) Matthew J. Sorrentino Heart Failure Clinics
- Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
- (2019) Aline Gottlieb et al. Cells
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
- (2019) Mohammad Shadab Siddiqui et al. JOURNAL OF HEPATOLOGY
- Animal models of NAFLD from the pathologist's point of view
- (2018) Helmut Denk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model
- (2018) François Briand et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet
- (2018) Yuta Miyaoka et al. EXPERIMENTAL ANIMALS
- Species differences in bile acids I. Plasma and urine bile acid composition
- (2018) Rhishikesh Thakare et al. JOURNAL OF APPLIED TOXICOLOGY
- A High-Fat and High-Cholesterol Diet Induces Cardiac Fibrosis, Vascular Endothelial, and Left Ventricular Diastolic Dysfunction in SHRSP5/Dmcr Rats
- (2018) Shogo Watanabe et al. Journal of Atherosclerosis and Thrombosis
- Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
- (2018) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Role of canonical Hedgehog signaling pathway in liver
- (2018) Lili Gao et al. International Journal of Biological Sciences
- Longitudinal micro-ultrasound assessment of the ob/ob mouse model: evaluation of cardiovascular, renal and hepatic parameters
- (2017) N Di Lascio et al. INTERNATIONAL JOURNAL OF OBESITY
- Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk
- (2016) Sarmad Said et al. Current Vascular Pharmacology
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice
- (2016) Yang Xu et al. HEPATOLOGY
- Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans
- (2016) Shogo Takahashi et al. JOURNAL OF LIPID RESEARCH
- Nonalcoholic fatty liver disease
- (2015) Timothy Hardy et al. CURRENT OPINION IN GASTROENTEROLOGY
- Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
- (2015) Samar H. Ibrahim et al. DIGESTIVE DISEASES AND SCIENCES
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- PPARs: Protectors or Opponents of Myocardial Function?
- (2015) Christine J. Pol et al. PPAR Research
- Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study
- (2014) Pauliina Pisto et al. BMJ Open
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- (2013) Kento Imajo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology
- (2013) Richard J. Johnson et al. Obesity
- High-Fat and Fructose Intake Induces Insulin Resistance, Dyslipidemia, and Liver Steatosis and Alters In Vivo Macrophage-to-Feces Reverse Cholesterol Transport in Hamsters
- (2012) François Briand et al. JOURNAL OF NUTRITION
- Use of hamster as a model to study diet-induced atherosclerosis
- (2011) Alice Dillard et al. Nutrition & Metabolism
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- (2009) S. A. Bustin et al. CLINICAL CHEMISTRY
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis
- (2008) Carolin Lackner et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now